COMMUNIQUÉS West-GlobeNewswire

International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease

29/11/2017 - 14:30

CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company [...]

Avid Bioservices Announces Appointment of Tracy Kinjerski as Vice President of Business Operations

29/11/2017 - 14:05

TUSTIN, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), today announced the appointment of Tracy L. [...]

Zogenix Announces Initiation of Phase 3 Trial for ZX008 in Lennox-Gastaut Syndrome

29/11/2017 - 14:05

EMERYVILLE, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]

Cancer Genetics Initiates Partnership to Reduce Alarmingly Increasing Cancer Mortality Rates in India

29/11/2017 - 14:02

Collaboration with India’s premier professional oncology organization, the Indian Cooperative Oncology Network (ICON) Goal to bring CGI’s global expertise in clinical diagnostic assay development and as a drug [...]

PhaseBio Announces $15.6 Million in Funds to Support Clinical Advancement of Orphan Cardiovascular Pipeline

29/11/2017 - 14:00

Entered into $7.5 million term loan facility with Silicon Valley Bank Closed $8.1 million second tranche of convertible notes announced in January 2017 Funds will be used to advance clinical development of PB1046 in [...]

Biotricity Recognizes Remote Monitoring is Key to Chronic Care Management

29/11/2017 - 14:00

REDWOOD CITY, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

ONC Health IT Certification Program Director Joins EHNAC as Ex Officio Commissioner

29/11/2017 - 14:00

FARMINGTON, Conn., Nov. 29, 2017 (GLOBE NEWSWIRE) -- The Electronic Healthcare Network Accreditation Commission (EHNAC), a non-profit standards development organization and accrediting body for organizations that [...]

CASMED to Present at the LD Micro Main Event Conference

29/11/2017 - 14:00

BRANFORD, Conn., Nov. 29, 2017 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and [...]

scPharmaceuticals Inc. Announces Closing of Initial Public Offering

29/11/2017 - 14:00

BURLINGTON, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company”) a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way [...]

Zogenix to Participate in the Global Mizuho Investor Conference 2017

29/11/2017 - 14:00

EMERYVILLE, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]

Inovio’s Further Analysis of VGX-3100 Phase 2b Data Reveals Immune Correlates and Biomarker Signatures That Predicted Clinical Efficacy

29/11/2017 - 14:00

PLYMOUTH MEETING, Pa., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that post-hoc analysis of data generated from its phase 2b trial of VGX-3100 identified immune [...]

Aeglea BioTherapeutics Doses First Pediatric Patient with Arginase 1 Deficiency in its Phase 1/2 Trial with Pegzilarginase (AEB1102)

29/11/2017 - 14:00

AUSTIN, Texas, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a biotechnology company committed to the discovery and development of engineered human enzyme therapeutics for patients with [...]

Cancer Genetics and Indian Cooperative Oncology Network (ICON) Collaborate to Reduce Alarmingly Increasing Cancer Mortality Rates

29/11/2017 - 14:00

Goal to bring CGI’s global expertise in clinical diagnostic assay development and as a drug development partner to optimize clinical outcomes for cancer patients; Aim to develop educational and collaborative clinical [...]

Protalix BioTherapeutics Completes Enrollment in Phase II Clinical Trial of OPRX-106 in Patients with Ulcerative Colitis

29/11/2017 - 13:55

CARMIEL, Israel, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), announced today the completion of enrollment in the Company’s phase II clinical trial evaluating OPRX- [...]

A Personal Letter to the Shareholders from Michael T. Redman, CEO of Oncolix, Inc.

29/11/2017 - 13:30

HOUSTON, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTC PINK:ONCX) a company focused on developing new cancer therapeutics, announces a letter from the CEO. My fellow shareholders, First, I would like to thank [...]

U.S. FDA Grants Fast Track Designation for Idera Pharmaceuticals’ IMO-2125 in Combination with Ipilimumab for Treatment of PD-1 Refractory Metastatic Melanoma

29/11/2017 - 13:30

CAMBRIDGE, Mass. and EXTON, Pa., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients [...]

Actinium Pharmaceuticals Highlights Strong Presence at 59th Annual American Society of Hematology Meeting Evidenced by Clinical Development Progress and Results Showcasing its AWE Technology Platform

29/11/2017 - 13:30

- Poster presentation to detail results from ongoing Phase 2 trial for Actimab-A, Actinium’s CD33 targeting ARC or Antibody Radio-Conjugate, designed to explore Actimab-A’s efficacy in patients newly diagnosed with [...]

Peer-Reviewed Article Published on Pluristem’s PLX-PAD Cells’ Mechanism of Action to Restore Blood Flow in Ischemic Tissue

29/11/2017 - 13:00

HAIFA, Israel, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc . (NASDAQ: PSTI ) (TASE: PSTI ), a leading developer of placenta-based cell therapy products, announced the publication of a peer-reviewed [...]

Aviragen Therapeutics Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of Teslexivir (BTA074) for the Treatment of Condyloma

29/11/2017 - 13:00

ATLANTA, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ), a company focused on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic [...]